Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 52, 2010, Pages 22745-22750

  Mizuno, Hideaki ^a,b   Spike, Benjamin T ^c   Wahl, Geoffrey M ^c   Levine, Arnold J ^a,d  

^a INSTITUTE FOR ADVANCED STUDY   (United States)

^b Chugai Pharmaceutical   (Japan)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL CYCLE; CELL DIFFERENTIATION; DNA RECOMBINATION; DNA REPLICATION; EMBRYONIC STEM CELL; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG CANCER; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; STEM CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH;

BREAST NEOPLASMS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LUNG NEOPLASMS; MUTATION; NEOPLASTIC STEM CELLS; REPRESSOR PROTEINS; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78651100119     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017001108     Document Type: Article

References (37)

1. Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924-935.
2. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9:138-141.
3. Stingl J, Caldas C (2007) Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7:791-799.
4. Gupta PB, Chaffer CL, Weinberg RA (2009) Cancer stem cells: Mirage or reality? Nat Med 15:1010-1012.
5. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
6. Yamanaka S (2007) Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1:39-49.
7. Yu J, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
8. Banito A, et al. (2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 23:2134-2139.
9. Kawamura T, et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460:1140-1144.
10. Marión RM, et al. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460:1149-1153.
11. Hanna J, et al. (2009) Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462:595-601.
12. Hong H, et al. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460:1132-1135.
13. Li H, et al. (2009) The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460:1136-1139.
14. Ben-Porath I, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499-507.
15. Hassan KA, Chen G, Kalemkerian GP, Wicha MS, Beer DG (2009) An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma. Clin Cancer Res 15:6386-6390.
16. Mootha VK, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273.
17. Assou S, et al. (2007) A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25:961-973.
18. Miller LD, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102:13550-13555.
19. Langerød A, et al. (2007) TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res 9:R30.
20. Tomida S, et al. (2009) Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J Clin Oncol 27:2793-2799.
21. Li J, et al. (2002) Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet 31:133-134.
22. Lee TI, et al. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125:301-313.
23. Lee KH, et al. (2010) A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci USA 107:69-74.
24. Sørlie T, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874.
25. Weigelt B, et al. (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216:141-150.
26. de Cremoux P, et al. (1999) p53 mutation as a genetic trait of typical medullary breast carcinoma. J Natl Cancer Inst 91:641-643.
27. Kochhar R, Howard EM, Umbreit JN, Lau SK (2005) Metaplastic breast carcinoma with squamous differentiation: Molecular and clinical analysis of six cases. Breast J 11:367-369.
28. Hennessy BT, et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116-4124.
29. Krizhanovsky V, Lowe SW (2009) Stem cells: The promises and perils of p53. Nature 460:1085-1086.
30. Puzio-Kuter AM, Levine AJ (2009) Stem cell biology meets p53. Nat Biotechnol 27:914-915.
31. Weigelt B, Reis-Filho JS (2009) Histological and molecular types of breast cancer: Is there a unifying taxonomy? Nat Rev Clin Oncol 6:718-730.
32. McCarthy A, et al. (2007) A mouse model of basal-like breast carcinoma with metaplastic elements. J Pathol 211:389-398.
33. Yan H, et al. (2010) Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice. Am J Pathol 176:1421-1432.
34. Kim J, et al. (2010) A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143:313-324.
35. Wang B, Xiao Z, Ko HL, Ren EC (2010) The p53 response element and transcriptional repression. Cell Cycle 9:870-879.
36. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
37. Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.